When can personal best peak flow be determined for asthma action plans?
Open Access
- 1 November 2004
- Vol. 59 (11) , 922-924
- https://doi.org/10.1136/thx.2004.023077
Abstract
Background: Written asthma action plans based on personal best peak expiratory flow (PEF) consistently improve health outcomes, whereas those based on predicted PEF do not. Guidelines state that personal best PEF should be assessed over 2–3 weeks during good asthma control, but it is unclear how long to wait after commencing or changing treatment. Methods: Electronically recorded spirometric data from 61 subjects with initially poorly controlled asthma from a 72 week budesonide study were analysed. For each week, average morning pre-bronchodilator PEF was calculated and personal best PEF was determined as the highest PEF in the previous 2 weeks. The time to plateau was defined as the week beyond which no further improvement occurred. Results: At baseline, average morning PEF was 61% predicted and personal best PEF was 87% predicted. Personal best PEF from twice daily monitoring increased to a plateau of 95% predicted (pConclusions: Personal best PEF is a useful concept for asthma self-management plans when determined as the highest PEF over the previous 2 weeks. With twice daily monitoring, personal best PEF reaches plateau levels after only a few weeks of corticosteroid treatment.Keywords
This publication has 10 references indexed in Scilit:
- Written action plans for asthma: an evidence-based review of the key componentsThorax, 2004
- Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonideThorax, 2004
- Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001The Medical Journal of Australia, 2003
- Inaccuracy of “Personal Best” Peak Expiratory Flow Rate Reported by Inner-City Patients with Acute AsthmaJournal of Asthma, 2001
- Optimal asthma control, starting with high doses of inhaled budesonideEuropean Respiratory Journal, 2000
- Differences between asthma exacerbations and poor asthma controlThe Lancet, 1999
- Pitfalls in processing home electronic spirometric data in asthmaEuropean Respiratory Journal, 1998
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Patient non-compliance: Deviance or reasoned decision-making?Social Science & Medicine, 1992
- New regression equations for predicting peak expiratory flow in adults.BMJ, 1989